William Blair Downgrades Audentes Therapeutics (BOLD) to Market Perform
Get Alerts BOLD Hot Sheet
Price: $14.84 --0%
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Rating Summary:
1 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE
William Blair analyst Raju Prasad downgraded Audentes Therapeutics (NASDAQ: BOLD) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Audentes Therapeutics click here. For more ratings news on Audentes Therapeutics click here.
Shares of Audentes Therapeutics closed at $29.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monness, Crespi, Hardt Downgrades Palantir Technologies Inc. (PLTR) to Sell on 'egregiously rich valuation... darkest days of this economic downturn are ahead of us'
- William Blair Starts Solid Biosciences (SLDB) at Outperform, 'success in any of programs alone should provide severalfold upside from Solid’s current valuation'
- Morgan Stanley Downgrades Lite-On Technology Corp (2301:TT) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!